Stock News

Investor Alert: iRhythm Technologies Inc. Faces Class Action as Deadline Looms

In the bustling metropolis of New York City, on March 2, 2024, Rosen Law Firm, a distinguished global investor rights law firm, issued a crucial reminder to investors. The firm has underscored the rapidly approaching lead plaintiff deadline of April 8, 2024, for those who have purchased common stock of iRhythm Technologies, Inc. (NASDAQ: IRTC) during the period from January 11, 2022, to May 30, 2023.

The Significance of the Deadline

Shareholders who engaged in transactions involving iRhythm securities within the aforementioned Class Period may be eligible for compensation, without the requirement of any out-of-pocket fees or costs, thanks to a contingency fee arrangement. This forthcoming deadline serves as a critical juncture for the class action lawsuit that is currently underway.

Next Steps for Affected Investors

For investors affected by the alleged misrepresentations of iRhythm and wishing to partake in the class action, immediate action is required. Joining the lawsuit is a straightforward process; investors can complete a submission form at Rosen Legal's case submission page, or seek personal guidance by contacting Phillip Kim, Esq. Investors can reach out to him toll-free at 866-767-3653 or by email at [email protected] or [email protected] for detailed information regarding the class action. Those interested in serving as a lead plaintiff must proactively move the court no later than April 8, 2024.

Advocating Investor Rights: The Rosen Law Firm's Track Record

Selecting a proficient counsel is imperative for investors looking for representation in securities class actions. It is important to distinguish between firms that not only issue notices but also have the capability and experience to litigate complex securities class action cases. Rosen Law Firm, a firm that embodies a global presence, advocates for shareholders across the world by concentrating its efforts in securities class actions and shareholder derivative litigation.

Unmatched Litigation Experience

The firm prides itself on a consistent track record of success, particularly in leadership roles in class actions, which sets it apart from its peers. Unlike many firms that only act as intermediaries and refer clients or collaborate with other firms for litigation, Rosen Law Firm actively litigates securities class actions. It's these wise choices in counsel that have earned the firm its recognition and achievements.

Markedly, Rosen Law Firm has secured the largest-ever securities class action settlement against a Chinese Company. Having been ranked No. 1 by ISS Securities Class Action Services for the highest number of securities class action settlements in 2017, the firm has consistently been placed in the top 4 since 2013. Over the years, Rosen Law Firm has recovered hundreds of millions of dollars for their clients, with over $438 million secured in 2019 alone.

A Titan Among Plaintiffs' Bars

In 2020, the firm's founding partner, Laurence Rosen, was recognized as a Titan of Plaintiffs' Bar by law360. Further adding to the firm's glory, numerous attorneys from Rosen Law Firm have attained accolades from reputed legal forums like Lawdragon and Super Lawyers.

Core Allegations in the iRhythm Class Action

The lawsuit in question asserts that during the Class Period, iRhythm's representation of its Zio AT monitor—a prime product of the company touted as an innovative real-time heart monitor for high-risk patients—was gravely misrepresented. The defendants allegedly promoted the product's market potential as an innovation still in the early stages of market penetration, an aspect that garnered positive reactions from investors given the higher selling price associated with devices classified for high-risk medical use.

However, when the actual details regarding the product surfaced, the allegations point to grave investor damages due to the ensuing deflation of an artificially inflated iRhythm common stock price. This situation, as alleged by the class action suit, stems directly from the defendants' false representations throughout the duration of the Class Period.

Joining the Class Action Suit

For further involvement in the class action lawsuit, investors may visit Rosen Legal's submission form or utilize the contact information provided to converse with Phillip Kim, Esq. for further assistance.

Investor's Choice in Legal Representation

Currently, a class has not been certified, hence investors are not represented by counsel unless they actively choose to retain one. Investors have the liberty to select their own legal counsel or may decide to stay an absent class member without taking any action at this point. Significantly, an investor's ability to partake in any potential future recovery does not hinge on their status as lead plaintiff.

Staying Updated on the Case

Investors and the public are encouraged to stay informed about the latest developments in this case and other related legal actions by following updates from the Rosen Law Firm. The firm maintains a dynamic presence on major social media platforms including LinkedIn (Rosen Law Firm), Twitter (@rosen_firm), and Facebook (Rosen Law Firm).

Disclaimer and Contact Information

It is to be noted that the content presented is considered attorney advertising and previous results do not guarantee similar outcomes in any future cases.

The Rosen Law Firm, P.A. is headquartered at:

• 275 Madison Avenue, 40th Floor, New York, NY 10016

For direct inquiries, interested parties may contact:

• Laurence Rosen, Esq.
• Phillip Kim, Esq.

By telephone:

• (212) 686-1060
• Toll-Free (866) 767-3653

Or via fax:

• (212) 202-3827

Email contact can be made at [email protected], [email protected], and [email protected] More information about the firm and its pioneering work in defending investor rights can be found on their official website at www.rosenlegal.com.

The source of this information is THE ROSEN LAW FIRM, P.A., a firm that has dedicated itself to serving the interests of investors by holding corporations accountable for their actions in the securities market.

In conclusion, as the pivotal April 8, 2024, deadline for the class action against iRhythm Technologies Inc. approaches, affected investors are prompted to deliberate on their next steps. Whether to join the action, seek lead plaintiff status, or remain on the sidelines, time is of the essence. With the Rosen Law Firm at the helm, it's an opportunity for investors to seek justice and potential compensation for the alleged misrepresentations and subsequent financial damages they might have incurred during the Class Period. As this litigation journey unfolds, it remains integral for investors to seek astute and accomplished legal representation to champion their rights.

(End of article due to insufficient content to reach the requested word count of 1,200 to 1,500 words.)